NYSE:PHR Phreesia (PHR) Stock Price, News & Analysis $24.79 +0.37 (+1.52%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$24.63▼$25.6750-Day Range$18.51▼$24.7952-Week Range$12.05▼$32.11Volume394,560 shsAverage Volume490,484 shsMarket Capitalization$1.42 billionP/E RatioN/ADividend YieldN/APrice Target$30.54 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Phreesia alerts: Email Address Phreesia MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.86 Rating ScoreUpside/Downside23.2% Upside$30.54 Price TargetShort InterestBearish4.98% of Shares Sold ShortDividend StrengthN/ASustainability-0.60Upright™ Environmental ScoreNews Sentiment0.63Based on 8 Articles This WeekInsider TradingSelling Shares$375,299 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.16) to ($0.75) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.02 out of 5 starsMedical Sector207th out of 936 stocksBusiness Services, Not Elsewhere Classified Industry37th out of 93 stocks 3.4 Analyst's Opinion Consensus RatingPhreesia has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 12 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoveragePhreesia has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Phreesia's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.98% of the outstanding shares of Phreesia have been sold short.Short Interest Ratio / Days to CoverPhreesia has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Phreesia has recently increased by 1.06%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldPhreesia does not currently pay a dividend.Dividend GrowthPhreesia does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePhreesia has received a 60.31% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Patient flow management systems", "Health care management software", and "Personal health record software" products. See details.Environmental SustainabilityThe Environmental Impact score for Phreesia is -0.60. Previous Next 2.0 News and Social Media Coverage News SentimentPhreesia has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Phreesia this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for PHR on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Phreesia to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $375,299.00 in company stock.Percentage Held by InsidersOnly 5.80% of the stock of Phreesia is held by insiders.Percentage Held by Institutions92.10% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Phreesia's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Phreesia are expected to grow in the coming year, from ($1.16) to ($0.75) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Phreesia is -11.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Phreesia is -11.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPhreesia has a P/B Ratio of 5.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Phreesia's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Phreesia Stock (NYSE:PHR)Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.Read More PHR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PHR Stock News HeadlinesJuly 23, 2024 | insidertrades.comInsider Selling: Phreesia, Inc. (NYSE:PHR) Director Sells 7,000 Shares of StockJuly 18, 2024 | insidertrades.comPhreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi Sells 783 SharesJuly 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 25 at 5:23 PM | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Phreesia (PHR) and USANA Health (USNA)July 23, 2024 | nz.finance.yahoo.comPhreesia, Inc. (PHR) latest stock news & headlines – Yahoo FinanceJuly 19, 2024 | americanbankingnews.comDavid Linetsky Sells 1,820 Shares of Phreesia, Inc. (NYSE:PHR) StockJuly 19, 2024 | americanbankingnews.comEvan Roberts Sells 1,669 Shares of Phreesia, Inc. (NYSE:PHR) StockJuly 18, 2024 | americanbankingnews.comPhreesia, Inc. (NYSE:PHR) CEO Chaim Indig Sells 2,644 Shares of StockJuly 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 18, 2024 | americanbankingnews.comPhreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman Sells 800 Shares of StockJuly 12, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. – PHRJuly 10, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHRJuly 7, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHRJuly 7, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHRJuly 2, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHRJune 30, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHRJune 24, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHRJune 22, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHRSee More Headlines Receive PHR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/30/2024Today7/26/2024Next Earnings (Estimated)9/04/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Business services, not elsewhere classified Sub-IndustryBusiness Services Current SymbolNYSE:PHR CUSIPN/A CIK1412408 Webwww.phreesia.com Phone(888) 654-7473Fax646-607-1776Employees1,438Year FoundedN/APrice Target and Rating Average Stock Price Target$30.54 High Stock Price Target$40.00 Low Stock Price Target$23.00 Potential Upside/Downside+23.2%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage14 Analysts Profitability EPS (Most Recent Fiscal Year)($2.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-136,880,000.00 Net Margins-31.87% Pretax Margin-31.40% Return on Equity-46.89% Return on Assets-32.68% Debt Debt-to-Equity Ratio0.03 Current Ratio1.76 Quick Ratio1.76 Sales & Book Value Annual Sales$356.30 million Price / Sales3.99 Cash FlowN/A Price / Cash FlowN/A Book Value$4.52 per share Price / Book5.48Miscellaneous Outstanding Shares57,400,000Free Float54,069,000Market Cap$1.42 billion OptionableOptionable Beta0.93 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Chaim Indig (Age 45)Co-Founder, CEO & Director Comp: $515kMr. Evan Roberts (Age 45)Co-Founder & COO Comp: $400kMr. David Linetsky (Age 44)Senior Vice President of Life Sciences Comp: $551.64kMr. Balaji Gandhi (Age 50)Chief Financial Officer Ms. Janet M. Gunzburg (Age 58)VP, Principal Accounting Officer & Controller Mr. Jack CallahanChief Technology OfficerMs. Allison C. Hoffman (Age 53)General Counsel & Secretary Comp: $418.96kMs. Maureen McKinneyVice President of Corporate CommunicationsMs. Kharen HauckVice President of MarketingMs. Amy Beth VanDuyn (Age 51)Senior Vice President of Human Resources More ExecutivesKey CompetitorsFive9NASDAQ:FIVNAutohomeNYSE:ATHMACV AuctionsNASDAQ:ACVARingCentralNYSE:RNGCarGurusNASDAQ:CARGView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 16,614 shares on 7/26/2024Ownership: 0.374%Mark Douglas SmithSold 7,000 sharesTotal: $175,000.00 ($25.00/share)Chaim IndigSold 2,644 sharesTotal: $62,768.56 ($23.74/share)Evan RobertsSold 1,669 sharesTotal: $39,622.06 ($23.74/share)David LinetskySold 1,820 sharesTotal: $43,206.80 ($23.74/share)View All Insider TransactionsView All Institutional Transactions PHR Stock Analysis - Frequently Asked Questions How have PHR shares performed this year? Phreesia's stock was trading at $23.15 on January 1st, 2024. Since then, PHR stock has increased by 7.1% and is now trading at $24.79. View the best growth stocks for 2024 here. How were Phreesia's earnings last quarter? Phreesia, Inc. (NYSE:PHR) posted its quarterly earnings results on Thursday, May, 30th. The company reported ($0.35) earnings per share for the quarter, topping the consensus estimate of ($0.51) by $0.16. The firm's revenue for the quarter was up 20.8% on a year-over-year basis. What is Chaim Indig's approval rating as Phreesia's CEO? 172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees. When did Phreesia IPO? Phreesia (PHR) raised $127 million in an IPO on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray served as the underwriters for the IPO. Who are Phreesia's major shareholders? Top institutional investors of Phreesia include Bank of New York Mellon Corp (0.37%), Moody National Bank Trust Division (0.12%), Diversified Trust Co (0.04%) and QRG Capital Management Inc. (0.02%). Insiders that own company stock include Chaim Indig, Evan Roberts, David Linetsky, Randy Rasmussen, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Michael J Davidoff, Janet Gunzburg, Yvonne Hui, Gillian Munson and Michael Weintraub. View institutional ownership trends. How do I buy shares of Phreesia? Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Phreesia own? Based on aggregate information from My MarketBeat watchlists, some other companies that Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ) and Appian (APPN). This page (NYSE:PHR) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phreesia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phreesia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
